Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: A double-blind placebo-controlled study

Keyphrases

• Cannabis Use 100%
• Cannabis 100%
• Cognitive Behavioral Therapy 100%
• Escitalopram 100%
• Placebo-controlled Study 100%
• Urine Samples 50%
• Cannabis Users 50%
• Abstinence Rate 50%
• Cannabis Withdrawal Syndrome 50%
• Placebo-controlled 25%
• Placebo 25%
• Cognitive Behavior 25%
• Intention-to-treat Analysis 25%
• United States 25%
• Cognitive Motivation 25%
• Anxiety-depression 25%
• Dropout 25%
• Abstinence 25%
• Depression Score 25%
• Comorbid 25%
• Selective Serotonin Reuptake Inhibitors 25%
• Anxiety Scale 25%
• Treatment Programs 25%
• Δ9-tetrahydrocannabinol (Δ9-THC) 25%
• Tetrahydrocannabinol 25%
• Therapy Session 25%
• Treatment Study 25%
• High Dropout Rate 25%
• United Europe 25%
• Illegal Substances 25%
• Mood Symptoms 25%
• Motivational Enhancement Therapy 25%
• Escitalopram Treatment 25%

Neuroscience

• Placebo 100%
• Cannabis 100%
• Escitalopram 100%
• Cannabis Addiction 100%
• Cognitive Behavioral Therapy 100%
• Withdrawal Syndrome 22%
• Tetrahydrocannabinol 22%
• Behavior (Neuroscience) 11%
• Selective Serotonin Reuptake Inhibitor 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Cannabis 100%
• Escitalopram 100%
• Placebo-Controlled Study 100%
• Cannabis Addiction 100%
• Symptom 22%
• Placebo 22%
• Withdrawal Syndrome 22%
• Prematurity 11%
• Selective Serotonin Reuptake Inhibitor 11%
• Tetrahydrocannabinol 11%
• Dronabinol 11%